Copyright
©The Author(s) 2021.
World J Clin Cases. Oct 26, 2021; 9(30): 9182-9191
Published online Oct 26, 2021. doi: 10.12998/wjcc.v9.i30.9182
Published online Oct 26, 2021. doi: 10.12998/wjcc.v9.i30.9182
Hematology | Biochemistry | Marker | ||||||
Values | Normal range | Values | Normal range | Values | Normal range | |||
WBC | 6600 | 3300-8600/µL | TP | 7.4 | 6.6-8.1 g/dL | HBs Ag | - | |
Neutro. | 64.3 | 38.0%-71.0% | Alb | 4.2 | 4.1-5.1 g/dL | Anti-HBs | - | |
Lymph. | 29.7 | 21.0%-50.0% | BUN | 9 | 8-20 mg/dL | Anti-HBc | - | |
Eos. | 0.8 | 7.3% | Cre | 0.62 | 0.46-0.79 mg/dL | Anti-HCV | - | |
Bas. | 0.2 | 2.0% | AST | 18 | 13-30 IU/L | |||
Mon. | 5.0 | 3.0%-8.0% | ALT | 18 | 7-23 IU/L | CEA | 1.1 | < 5.8 ng/mL |
RBC | 493 | 386-492 ×104/μL | ALP | 179 | 106-322 IU/L | CA19-9 | 14 | < 37 IU/mL |
Hb | 14.0 | 11.6-14.8 g/dL | LDH | 145 | 124-222 IU/L | CA125 | 8 | < 35 IU/mL |
Ht. | 41.5 | 35.1%-44.4% | γ-GTP | 20 | 9-32 IU/L | |||
Plt. | 26.7 | 15.8-34.8 ×104/μL | ChE | 314 | 201-421 IU/L | |||
Na | 138 | 138-145 mEq/L | ||||||
Coagulation | K | 3.2 | 3.6-4.8 mEq/L | |||||
Values | Normal range | Cl | 104 | 101-108 mEq/L | ||||
PT | 111 | 70%-130% | P | 2.5 | 2.7-4.6 mg/dL | |||
PT-INR | 0.94 | 1.0 | Ca | 9.2 | 8.8-10.1 mg/dL | |||
APTT | 27.4 | 26.9-40.9 sec | CRP | 0.01 | < 0.14 mg/dL | |||
TG | 60 | 30-117 mg/dL | ||||||
HDL-C | 63 | 48-103 mg/dL | ||||||
LDL-C | 88 | 65-163 mg/dL |
- Citation: Koseki Y, Kamimura K, Tanaka Y, Ohkoshi-Yamada M, Zhou Q, Matsumoto Y, Mizusawa T, Sato H, Sakamaki A, Umezu H, Yokoyama J, Terai S. Rapid progression of colonic mucinous adenocarcinoma with immunosuppressive condition: A case report and review of literature. World J Clin Cases 2021; 9(30): 9182-9191
- URL: https://www.wjgnet.com/2307-8960/full/v9/i30/9182.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i30.9182